Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP905017.RAA923ud7e9PX0ghqJQNlP-Qb48SqqReqhBY7_fe9tAv4130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905017.RAA923ud7e9PX0ghqJQNlP-Qb48SqqReqhBY7_fe9tAv4130_provenance.
• NP905276.RAcvyr_Q3WEIB9YLLkxTjyN3m8dTqENCWIOfOdbvPYwqI130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905276.RAcvyr_Q3WEIB9YLLkxTjyN3m8dTqENCWIOfOdbvPYwqI130_provenance.
• NP408541.RAOoS01-HlK3RISalSn6wiZ8WLvz7cjm9YAngg9vWYZeI130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP408541.RAOoS01-HlK3RISalSn6wiZ8WLvz7cjm9YAngg9vWYZeI130_provenance.
• assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP309036.RAc2rU1c-woFSCQJ6dN6ZPdIOZt3BHbrIt0DOA3dpZyac130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309036.RAc2rU1c-woFSCQJ6dN6ZPdIOZt3BHbrIt0DOA3dpZyac130_provenance.
• NP977730.RAm_0Ja0aR68k2SoVYpyIjhNKHSvsWDeNFWVAFIidyhZU130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977730.RAm_0Ja0aR68k2SoVYpyIjhNKHSvsWDeNFWVAFIidyhZU130_provenance.
• NP309039.RAp11QDPDm1R1Q_VybZTAyZWfnA-bQgr1NdeMHy8iucbs130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309039.RAp11QDPDm1R1Q_VybZTAyZWfnA-bQgr1NdeMHy8iucbs130_provenance.
• NP309040.RAni7nsVZXKa53KaiW_F0p16wxVATrBhR4Puc6SFyXKq0130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309040.RAni7nsVZXKa53KaiW_F0p16wxVATrBhR4Puc6SFyXKq0130_provenance.
• NP638440.RApPoAf6pwlcIKb4jWTFZmvnq7SwxNCo8Ix3vT8FX39yM130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638440.RApPoAf6pwlcIKb4jWTFZmvnq7SwxNCo8Ix3vT8FX39yM130_provenance.
• NP977841.RAE9v5hwXivaQl3SgjHucfz_ppaqD0OZ6p-qdCvhzWAYQ130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977841.RAE9v5hwXivaQl3SgjHucfz_ppaqD0OZ6p-qdCvhzWAYQ130_provenance.
• NP977876.RA24n3yBV38wkOmLZU-CQx1oN9ArOajjNSxAWdh8WaLKo130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP977876.RA24n3yBV38wkOmLZU-CQx1oN9ArOajjNSxAWdh8WaLKo130_provenance.
• NP309038.RAwKBSQuhCGg6z7LJhFUxqReX9MMArueDR3u8VdPKj4y4130_assertion description "[The polymorphic marker which we characterized was useful in determining allelic loss at the CyP40 locus in breast cancer patients and when applied in these studies in conjunction with various cancer-associated gene markers, suggests that deletions in the region of the CyP40 gene might be a late event in breast tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP309038.RAwKBSQuhCGg6z7LJhFUxqReX9MMArueDR3u8VdPKj4y4130_provenance.